Joint Working That Works
We brought together a group of experts from a broad range of clinical specialities and industry roles to look at the key elements of effective collaboration, as well as analyse the problems that can arise in a partnership project.
Both pharma and clinicians see huge benefits to joint working. When it works well, the sharing of resources, knowledge and skills enables them to achieve things they couldn’t do alone. Asked to score joint working out of 10 in terms of the value it can deliver for patients, the NHS and pharma the group rated it 7.7, 7.1 and 7.5 respectively. Working with stakeholders on areas of commonality means that companies are able to achieve commercial goals while improving patient outcomes and experience at the same time; the results are more than the sum of their parts.
The open and interactive discussion on barriers to joint working showed a striking similarity in the pitfalls experienced across both sectors. Issues include a lack of time, capacity and resources to set projects up properly; teams not having the right skills and capabilities to plan and manage joint working effectively; short-termism; misaligned objectives; bureaucracy and fear of reputational damage.
Our delegates told us they found the collaborative experience at the meeting stimulating, insightful and fun. One senior clinician told us he thought joint working was ‘vital to the future of the NHS’ while others suggested additional tools and resources that could help upskill both pharma and clinical teams.
We’re currently collating all the insights into a report. Contact firstname.lastname@example.org if you’d like a copy of this in due course.